Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.919162563491099.3656
Domestic EquitiesLupin Limited8.44912883991667.3267
Domestic EquitiesDivi's Laboratories Limited6.4058850754505.9434
Domestic EquitiesDr. Reddy's Laboratories Limited5.95773749746470.5556
Domestic EquitiesCipla Limited5.41723495054427.8645
Domestic EquitiesApollo Hospitals Enterprise Limited5.1550548795407.1510
Domestic EquitiesMedPlus Health Services Limited3.85733627277304.6550
Domestic EquitiesAjanta Pharma Limited3.3609946323265.4531
Domestic EquitiesMax Healthcare Institute Limited3.23852658082255.7872
Domestic EquitiesVijaya Diagnostic Centre Limited3.14832886684248.6590
Domestic EquitiesSai Life Sciences Limited3.14522555745248.4184
Domestic EquitiesMankind Pharma Limited2.87271131195226.8951
Domestic EquitiesAurobindo Pharma Limited2.81191702630222.0911
Domestic EquitiesIPCA Laboratories Limited2.76671364742218.5225
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.6397913226208.4895
Domestic EquitiesAbbott India Limited2.434274187192.2556
Domestic EquitiesAlkem Laboratories Limited2.1716323678171.5170
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.0901799649165.0795
Domestic EquitiesDr. Lal Path Labs Limited2.02381218224159.8432
Domestic EquitiesThyrocare Technologies Limited1.94384392120153.5266
Domestic EquitiesPfizer Limited1.9021318249150.2294
Domestic EquitiesGland Pharma Limited1.7191800549135.7811
Domestic EquitiesNarayana Hrudayalaya Limited1.6746823911132.2624
Domestic EquitiesEmcure Pharmaceuticals Limited1.5077746337119.0781
Domestic EquitiesSanofi Consumer Healthcare India Limited1.162721365991.8349
Domestic EquitiesSuraksha Diagnostic Limited1.1245389634988.8173
Domestic EquitiesFortis Healthcare Limited1.1111110388987.7592
Domestic EquitiesSanofi India Limited0.935823027273.9104
Domestic EquitiesSyngene International Limited0.9297188337273.4327
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8942151526470.6265
Domestic EquitiesAnthem Biosciences Limited0.8795105850369.4643
Domestic EquitiesBiocon Limited0.6714146937453.0297
Domestic EquitiesAstraZeneca Pharma India Limited0.61526256848.5872
Domestic EquitiesIndoco Remedies Limited0.3810183492430.0928
Domestic EquitiesConcord Biotech Limited0.144111173811.3794
Total 99.4612 7855.6850
Cash & Cash Equivalents and Net AssetsTriparty Repo0.8613 68.0240
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0054 0.4283
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.3279 -25.8956
Total 0.5388 42.5567
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.